(from the National Cancer Institute's Physician Data Query system, July 2002)
Prognostic factors include grade of tumor, depth of myometrial invasion, and histology. High estrogen receptor levels have a favorable impact on prognosis.
Stage 0 | 100% |
Stage I | 70-95% |
Stage II | up to 55% |
Stage III | up to 25% |
Stage IV | up to 5% |
Hydatidiform mole 100% (if treated properly).